illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10— 510(k) K160829
Substantially EquivalentMeridian Bioscience, Inc.
FDA 510(k) clearance K160829 for illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10, Substantially Equivalent on 2016-06-13. Applicant: Meridian Bioscience, Inc.. Device class: 2.
Clearance details
- Applicant
- Meridian Bioscience, Inc.
- Product code
- Code OZX
- Device class
- Class 2
- Regulation
- 21 CFR 866.3980
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Cincinnati, OH, US
Recent devices under product code OZX
view allMore clearances from Meridian Bioscience, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.